To sustain rapid proliferation, malignant cells must fundamentally rewire their metabolic infrastructure. They shift from highly efficient mitochondrial oxidative phosphorylation to rapid, less efficient aerobic glycolysis—a metabolic pivot known as the Warburg effect. While classical models attribute this shift to transcriptional changes in the nucleus, a sophisticated layer of post-transcriptional control operates directly on the cell's RNA pool. By manipulating the life cycle, structure, and stability of RNA molecules, cells can rapidly tune their metabolic state to favor survival, biomass production, and growth.
Competing Endogenous RNA Logic and Molecular Sponges
In a healthy cell, microRNAs (miRNAs) act as natural brakes on metabolic machinery. These short non-coding RNAs bind to complementary sequences on messenger RNAs (mRNAs), targeting them for degradation or blocking their translation. To overcome this suppression, aggressive cells deploy long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) that function as competitive endogenous RNAs (ceRNAs), or "molecular sponges." These sponges possess multiple binding sites that mimic the target mRNAs, effectively soaking up miRNAs and releasing the brakes on metabolic enzymes.
[ lncRNA / circRNA Sponge ] <--- Sequesters --- [ microRNA ]
|
(Normal Inhibition Blocked)
v
[ Metabolic mRNA Expression ]
|
v
Enhanced Glycolytic Flux
This competitive logic allows for rapid, coordinated shifts in metabolic pathways. For example, Huilin Ye et al. demonstrated that the lncRNA TUG1 sponges miR-145, which prevents the silencing of the Sirt3/GDH axis and drives a metabolic shift toward increased glutaminolysis. Similarly, Xiang Gao et al. showed that the circular RNA circ_0136666 sequesters miR-1244, upregulating CEP55 and downstream glycolytic enzymes like hexokinase 2 (HK2) and pyruvate kinase M2 (PKM2).
This sponge mechanism is highly tunable and directly dictates the rate of glucose consumption and lactate production. Zijian Feng et al. found that the lncRNA PVT1 sponges miR-187-3p to accelerate glucose metabolism, while Nan Yang et al. emphasized that circRNAs broadly act as critical master switches of aerobic glycolysis.
Conversely, tumor-suppressive non-coding RNAs can reverse this effect. Zhigao Zhang et al. illustrated how the lncRNA FLG-AS1 sponges miR-23a-3p to restore HOXD10 expression, successfully dampening glycolysis and reducing lactic acid production. Beyond non-coding RNAs, epigenetic silencing can also disrupt these protective networks; Bo Zeng et al. found that DNMT1-mediated methylation silences miR-124-3p, unleashing the metabolic driver BCAT1, while Youqin Xu et al. (2021) noted that downregulating specific microRNAs like miR-1185-2-3p allows uncontrolled expression of proteins that stabilize glycolytic pathways.
Epitranscriptomic Barcoding and Transcript Stability
Beyond sequestration, cells directly alter the chemical structure of mRNA to control its lifespan. This layer of regulation, known as the epitranscriptome, relies on "writer" enzymes to add chemical tags like $N^6$-methyladenosine ($m^6A$) to transcripts, altering how they are recognized by downstream processing machinery.
By tagging specific transcripts, cells can selectively extend the half-life of the machinery required for glycolysis. For example, the authors of a study on colorectal cancer discovered that the transcription factor HES1 upregulates the RNA-binding protein IGF2BP2. This protein then binds to and stabilizes the mRNA of the glucose transporter GLUT1 via m6A modification, ensuring a sustained supply of glucose to the cell.
[ HES1 Transcription Factor ]
|
v
[ IGF2BP2 RBP Up-regulation ]
|
v
[ m6A Tagging of GLUT1 mRNA ] ---> Increases Transcript Half-Life ---> Sustained Glycolysis
Conversely, epitranscriptomic tags can be used to target tumor suppressors for destruction. Youqin Xu et al. (2023) demonstrated that the methyltransferase METTL3 deposits m6A tags onto the mRNA of the tumor suppressor LATS1, signaling the reader protein YTHDF2 to degrade it, which deactivates the Hippo pathway and accelerates glycolytic metabolism. As reviewed by Xinru Chen et al. and Zehui Li et al., this epitranscriptomic barcoding allows malignant cells to maintain high rates of glycolysis and fatty acid metabolism even under severe environmental stress or nutrient deprivation.
Splicing and Decay Dynamics as Metabolic Switches
The final layer of RNA-mediated metabolic control involves RNA-binding proteins (RBPs) that dictate how transcripts are spliced or how quickly they decay. Rather than changing how much mRNA is transcribed, these proteins change which version of a protein is produced, or selectively eliminate competing metabolic pathways.
A classic example is the choice between alternative splice variants of pyruvate kinase. Jianguo Feng et al. highlighted how the RBP hnRNP A1 acts as a molecular switch, favoring the expression of the PKM2 isoform over PKM1, which directly drives the Warburg effect. Similarly, Lili Yu et al. found that the RNA helicase MTR4 recruits the splicing factor PTBP1 to orchestrate the alternative splicing of both GLUT1 and PKM2, forcing a transition from oxidative phosphorylation to glycolysis.
Alternatively, cells can actively suppress oxidative phosphorylation by accelerating the destruction of its corresponding mRNAs. Cancan Zhang et al. showed that the protein PUF60 localizes to cellular P-bodies—the sites of RNA clearance—where it accelerates the decay of mRNAs responsible for oxidative phosphorylation, effectively starving the cell of mitochondrial energy production and forcing a reliance on glycolysis. This broad capacity for RBPs to act as metabolic master switches is further exemplified by proteins like TDP-43, which Bowen Liu et al. identified as a central regulator coordinating glucose, lipid, and ATP pathways through microRNA repression and direct RNA processing.
Reversing the Switch
Understanding these post-transcriptional mechanisms reveals new therapeutic strategies to disrupt cancer metabolism. Because these RNA pathways are highly dynamic, they can be targeted or reversed by upstream signaling molecules.
For instance, Xiumei Huang et al. demonstrated that extracellular vesicles derived from Lactobacillus plantarum can downregulate SIRT5, preventing the desuccinylation of p53. This locks p53 into an active state, which subsequently represses the expression of glucose transporters and glycolytic enzymes, effectively reversing the Warburg effect. By targeting the non-coding RNAs, epitranscriptomic writers, and splicing factors that maintain these metabolic networks, researchers aim to strip malignant cells of their primary energy source.
Key Foundational Work
LncRNA TUG1 sponges miR-145 to promote cancer progression and regulate glutamine metabolism via Sirt3/GDH axis (2017) — contributed 1 concept elements to this direction.
The role of DNMT1/hsa-miR-124-3p/BCAT1 pathway in regulating growth and invasion of esophageal squamous cell carcinoma (2019) — contributed 1 concept elements to this direction.